Intel (INTC)
Verdict history · INTC
Every call Verdix has made on INTC.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
The prior WAIT article flagged an impending pullback below $95, and that pullback has arrived — price declined 12% from $102.50 to $90 on expanding volume, landing the stock in no-man's-land: too far above the $80-83 support zone to buy, too far along in the correction to sell. The panel shifts to BALANCED because the correction they forecast is now materializing, and selling into a decline that was explicitly anticipated would contradict the original thesis, but the technical and insider signals all argue the move is not finished.
See methodology for how verdicts are produced. Full track record →
Why the panel isn’t ready to call INTC yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Semiconductors / Foundry · 2026-06-29 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends on Intel after a 5-7x government-backed turnaround rally: a real reshoring story — US-government stake, Nvidia capital, 18A ramping — wrapped around a business that is still loss-making, with the foundry bleeding ~$2.4B a quarter and fair value clustering far below a parabolic price. The debate and the key levels.Level to watch
Key resistance 150+4.9% from 143.06
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 143.06 (as of 2026-06-29)
Intel is the panel's sharpest "great story, wrong price" standoff. The turnaround is real and, in places, remarkable: an August-2025 US-government conversion of CHIPS grants into a ~10% equity stake (433M shares at $20.47) erased the solvency risk, Nvidia put $5B of common equity to work co-developing x86/data-center silicon, Q1 2026 blew through guidance (revenue $13.6B, sixth straight beat, DCAI +22%), and 18A is ramping with early external interest from Microsoft, Amazon, and reported Apple foundry talks. That is what drove the stock ~5-7x off its $20-30 low to a ~$141-143 all-time high. But the same company is still loss-making — Intel Foundry lost ~$2.4B in the quarter, GAAP net loss was ~$3.7B, free cash flow is negative — and the price now sits at roughly 114x forward earnings, ~3x the semis median, with most intrinsic-value models (and the analyst consensus target ~30% below the quote) pointing far lower. Four of six frameworks are bearish on the price; the two bulls are momentum-and-theme buyers who themselves flag that parabolas implode. The objection is unanimous and specific — not "the turnaround is fake," but "you are paying for a flawless multi-year foundry pivot that hasn't shown up in the margins yet." With the business improving but the price discounting perfection into a vertical chart, the synthesis is WAIT.
Key levels
Key levels · INTC
USD · as of 2026-06-29Analyst consensus target 98 USD · range 75–150
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at the ~$142 all-time-high shelf, with little overhead history above it — a parabolic advance has no prior structure, so the round-number ~$150 and ~$165 levels are projection, not memory. Key support sits at ~$128 (the late-June pullback low), then a ~$100 psychological zone, with a deeper structural base near $75 — the levels a froth-deflation would test. The analyst consensus target spans roughly USD 75 to 150, averaging near USD 98 — about 30% below the current price, an unusual configuration in which the Street's average target sits under the quote, underscoring how far the tape has run ahead of published estimates.
What legendary investors think
We ran Intel past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🔴 BearishHigh
"A turnaround priced like a triumph." The government stake and Nvidia capital removed bankruptcy risk, but Intel "still hasn't earned its cost of capital" — the foundry is a capital furnace losing ~$2.4B a quarter, ROE is negative, and at ~114x forward earnings "you're paying a winner's multiple for a company still proving it can win." Outside the fat-pitch zone by a wide margin.
The GARP OperatorGrowth (GARP)🔴 BearishMedium
"The stock turned in price, not in earnings." A 5-7x move with the company still posting GAAP losses is "the chart running miles ahead of the fundamentals." With the analyst average near $98 — below the price — "the market has already paid for a turnaround that's still mostly a slide deck." Wait for real foundry profit, not promises.
The Disruptive-Innovation SeekerGrowth🟢 BullishMed
"Reshored leading-edge silicon is a genuine S-curve, and Intel is the only Western foundry on it." 18A yields improving, a US-government anchor owner, and Microsoft/Amazon/Apple interest make this "the strategic asset the AI build-out can't do without." Sees a multi-year compounding case if 18A converts — sized for volatility, not perfection.
The Intrinsic-Value ModelerValuation🔴 BearishMed-High
The story is improving but the numbers aren't there: negative FCF, a loss-making foundry, and a DCF that needs heroic 18A volume to clear today's price. Fair value ~$60-75 on current fundamentals — "a 50%+ gap to the quote." "A better business than a year ago, but the price moved more than the business did."
The Forensic SkepticContrarian🔴 BearishHigh
"This is a blow-off, not a re-rating." Still loss-making at ~113-130x forward earnings, with the government stake, the Nvidia issuance, and a SoftBank position all adding to a share count that dilutes owners. Intrinsic ~$30-40. "The capital that saved Intel from bankruptcy is the same capital diluting anyone buying the parabola."
The Macro OpportunistMacro🟢 BullishMed
"I won't fight a government that's long the equity, and reshoring is the policy trade of the decade." The theme and the tape have been right — but "parabolas implode," and this one is vertical and extended above every reference line. Would ride momentum with a tight leash and trim into strength, "not initiate a full position at the top of a 5-7x run."
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The turnaround is real: the US-government ~10% stake and Nvidia's $5B removed solvency risk, and Q1 2026 genuinely beat (revenue $13.6B, sixth straight beat, DCAI +22%).
- The company is still loss-making: Intel Foundry lost ~$2.4B in the quarter, GAAP net loss ~$3.7B, free cash flow negative — the profitability hasn't arrived yet.
- The valuation is stretched:
114x forward earnings (≈3x the semis median), with the analyst consensus target ($98 average) sitting below the price. - The chart is parabolic: a 5-7x advance off the $20-30 low to an all-time high, extended far above every trend reference.
The real debate
- Strategic asset or capital furnace? The growth lens sees the only Western leading-edge foundry on a reshoring S-curve, anchored by a government owner; the value and forensic lenses see a business still losing billions at the foundry with no earned cost of capital.
- Re-rating or blow-off? The macro and growth lenses say the theme is structurally right and momentum is real; the skeptic and valuation lenses say a still-loss-making company at 100x+ forward earnings is a euphoric top, not a sustainable re-rating.
- Does the rescue capital help or dilute? Bulls treat the government/Nvidia/SoftBank capital as validation; the Forensic Skeptic notes the same issuance dilutes anyone buying in now.
The question it comes down to: Is Intel a once-in-a-generation reshoring asset whose government-and-Nvidia backing justifies owning the only Western leading-edge foundry through the volatility — or a still-loss-making turnaround whose price has run 5-7x ahead of margins that don't yet exist, with fair value and the Street's own targets sitting far below the quote?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 143.06 / ~$650-660B |
| P/E (TTM / fwd) | n/a (GAAP net loss) / ~114x |
| ROE | Negative (GAAP net losses) |
| Operating margin | Non-GAAP gross margin ~41%; Intel Foundry operating loss ~$2.4B (Q1) |
| Dividend yield | 0% (suspended) |
| Debt / equity | Cash & ST investments ~$37.4B; took on ~$6.5B new debt for Fab 34 |
| Free cash flow | Negative (Q1 adjusted FCF ~ -$2B; gross capex ~$5B) |
Figures as of Q1 2026 / June 2026; sourced from Intel IR/SEC filings, CNBC, Yahoo Finance, GuruFocus, Macrotrends. Trailing P/E is not meaningful (GAAP net loss); forward P/E (~114x) is from aggregators and reflects a thin, recovering earnings base. Intrinsic-value models show wide dispersion — bear case ~$30-50 on current fundamentals, bull case $120-150+ only if 18A/14A foundry wins convert to booked revenue by 2027-28. Catalyst sequence: US-government 10% stake (CHIPS conversion at $20.47, Aug 2025), Nvidia $5B equity (Sept 2025), Q1 2026 beat, reported Apple/Microsoft/Amazon foundry interest — most external 18A commitments remain 2027+ timelines, not booked revenue.
The bottom line
Intel is the panel's clearest case of a real turnaround colliding with a parabolic price. The bull side is grounded and, on the news flow, genuinely impressive: a US-government anchor owner that erased bankruptcy risk, Nvidia capital and co-development, a sixth straight earnings beat, an improving 18A node, and reported foundry interest from Microsoft, Amazon, and Apple — the makings of the only Western leading-edge foundry the AI build-out can't ignore. The caution is equally grounded and, this quarter, dominant: the company is still loss-making — the foundry bled ~$2.4B, GAAP net loss was ~$3.7B, free cash flow is negative — while the stock has run 5-7x to ~114x forward earnings, roughly triple the semis median, with intrinsic-value estimates clustering from the $30s to the $70s and the analyst consensus target near $98, about 30% below the quote. Even the two bulls are momentum-and-theme buyers who say outright that vertical charts implode and that they'd trim, not initiate, here. What would tip the synthesis bullish is the turnaround showing up where it counts — foundry losses narrowing toward breakeven, 18A external commitments converting to booked revenue, and free cash flow turning positive — at which point the story stops being a slide deck and starts being earnings. What keeps it a wait is that, until then, the panel is being asked to pay a winner's multiple, into a parabola, for margins that don't yet exist — and the same strategic asset would be far more compelling once the froth deflates and the foundry proves it can earn its keep.
contact@verdixhq.com · Published 2026-06-29 · Prices as of 2026-06-29 · Time horizon: 3–12 months · Founder holds a direct position in INTC · INTC verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call INTC yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Semiconductors / Foundry · 2026-07-11 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends on Intel after a ~190% moonshot to a $141 high and a ~22% pullback: a genuine US-onshoring turnaround with a government equity stake and 18A finally shipping, but still unprofitable, cash-burning, and priced for flawless execution — analyst targets and intrinsic-value estimates both sit below the price. The debate and the key levels.Level to watch
Key support 104−5.3% from 109.84
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 109.84 (as of 2026-07-11)
Intel is the panel's clearest "the story is real, the price got ahead of it" call. The turnaround has genuine substance: the 18A process node is shipping its first products, the US government converted CHIPS funding into a 9-10% equity stake (aligning Washington behind the only leading-edge foundry on American soil), and a wave of evaluation interest from large customers has re-rated the stock roughly 190% off its 2025 base to a $140.94 high on June 22. But the panel is strikingly cautious, and the reason is arithmetic: Intel is still losing money (TTM net loss $174M in Q1), and the decisive 14A node depends on landing outside customers that haven't signed yet. With four of six lenses bearish on valuation, the long-term chart still in an uptrend, and a binary Q2 print due July 23, the synthesis is WAIT — a real turnaround whose stock has sprinted far ahead of the proof.$3.2B, Q1 operating margin negative), still burning free cash flow (-$4.9B in 2025, improving but negative), pays no dividend, and now carries a $555B market cap at north of 100x forward non-GAAP earnings — while the analyst consensus target ($101) sits below the current price and the panel's intrinsic-value work lands in the $60-75 range. Foundry's external revenue is still tiny (
Key levels
Key levels · INTC
USD · as of 2026-07-11Analyst consensus target 101 USD · range 25–200
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$118 (the reclaimed EMA, now overhead), then this move's ~$127 high, up to the ~$141 swing high / all-time high on the run. Key support sits at ~$104 (the recent weekly low), the ~$100 round-number zone, then a much deeper historical accumulation zone near ~$85 (the rising Supertrend line and the 2020-21 range). The analyst consensus target spans an extraordinarily wide USD 25 to 200 — averaging near USD 101, actually below the current price — which tells the whole story: this is a binary turnaround where the Street cannot agree whether the foundry bet is worth $25 or $200, and the midpoint says the stock has already run past fair value.
What legendary investors think
We ran Intel past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🔴 BearishHigh
"A turnaround, not a compounder — and turnarounds are outside what I want to own." ROE near -0.2% and negative free cash flow say the moat against TSMC has eroded badly; Foundry lost billions in a single quarter with 18A yields reportedly not profitable until 2026-27. "A company burning cash while ramping capex has no earnings power to value — I'd rather watch from the sidelines than guess when, or if, the moat comes back."
The GARP OperatorGrowth (GARP)⚫ NeutralLow
A classic turnaround, and "I don't use PEG here — there's no clean growth rate on near-breakeven earnings." Foundry revenue grew 20% sequentially but external foundry revenue was just ~$174M — "the paying-customer story is still tiny." Wants to see the July 23 print for real yield and external-customer commitments "before betting the turnaround is for real."
The Disruptive-Innovation SeekerGrowth🔴 BearishMedium
The US-onshoring optionality (18A/14A as a CHIPS-backed alternative to TSMC) is genuine, "but the S-curve is not yet proven and the window to matter for AI accelerators is narrowing fast." 14A customer commitments aren't expected until H2 2026-H1 2027 — "too late to call this early-adoption disruption today; it's speculative optionality, not a demonstrated cost curve against TSMC."
The Intrinsic-Value ModelerValuation🔴 BearishLow
A story-to-numbers DCF (mid-single-digit near-term growth, Foundry breakeven pushed to 2027+, margins recovering slowly to ~15% by 2029, ~9% WACC) yields fair value around $60-75. "The June run to $140 priced in bull-case execution that the results don't yet support." Wants $65-70 before getting interested — "today's price still embeds too much unproven foundry optionality."
The Forensic SkepticContrarian🔴 BearishMedium
"The cash math doesn't support the narrative yet" — Q1 adjusted FCF ~-$2B, consensus FCF negative through all of 2026, tool spend up ~25% YoY. The government's 433M-share stake at $20.47 "permanently diluted holders and subordinates shareholder interests to Washington's industrial policy." The ~22% round-trip off the high is the market "pricing the risk I'd been flagging, not ignoring it." Wants positive FCF confirmed first.
The Macro OpportunistMacro⚫ NeutralMedium
"Trend up, extension extreme." The policy tailwind is real — a government stake plus fresh foundry evaluations validate the story — but INTC sits ~79% above its own 200-day, "a bigger gap than the dot-com peak," into a binary July 23 print. "I don't fight the trend, but I don't chase euphoria either." Would build on a pullback toward $75-85 holding above a rising 200-day; out on a post-earnings break of the 50-day.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The turnaround has real substance: 18A shipping, a US-government equity stake, and a leading-edge foundry on American soil with genuine strategic value.
- The fundamentals are still weak: TTM net loss, negative-to-thin operating margin, negative free cash flow, no dividend.
- The valuation has run ahead of the proof: ~$555B cap at 100x+ forward earnings, with the analyst average target and every intrinsic-value estimate below the current price.
- The next real test is Q2 earnings on July 23 — yields, external-customer wins, and cash burn.
The real debate
- Optionality or overvaluation? The macro lens respects the policy-backed uptrend; the value, valuation, and forensic lenses say the price already discounts flawless execution that hasn't happened.
- Is 18A/14A early enough to matter? The innovation lens worries the window against TSMC is closing before 14A lands paying customers.
- How much does the government stake help vs. dilute? A strategic backstop for the business, but a permanent dilution and a new, non-shareholder set of priorities for the equity.
The question it comes down to: Is Intel a strategically indispensable US foundry whose turnaround is finally shipping — worth owning through the volatility — or a still-unprofitable, cash-burning business whose stock has already sprinted ~190% past intrinsic value on optionality that won't be proven until 14A lands paying customers?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 109.84 / ~555B |
| P/E (TTM / fwd) | Negative (TTM net loss) / ~110x+ non-GAAP |
| Q1 2026 revenue | USD 13.6B (+7% YoY); Q2 guide 13.8-14.8B, non-GAAP EPS ~$0.20 |
| ROE / gross margin | ~-3% / ~37% (operating margin negative) |
| Free cash flow | ~-$4.9B (2025), improving but still negative |
| Dividend | Suspended (since Q4 2024) |
| Balance sheet | Debt >$50B vs ~$21B cash; US government holds ~9-10% equity stake |
Figures as of Q1 2026 (reported Apr 2026) / July 11, 2026; sourced from Intel IR/SEC filings, TradingKey, TipRanks, StockAnalysis, MacroTrends, Forbes, CoinDesk. Foundry external revenue was ~$174M in Q1 (the paying-customer base is still tiny); 18A is shipping but reportedly not at profitable yields until 2026-27, and 14A depends on external customers not yet signed. The US government converted CHIPS funding into a 9-10% equity stake. Analyst consensus ($101 avg, range ~$25-200) sits below the price. Next print: July 23, 2026 (Q2 2026).
The bottom line
Intel is the panel's most polarizing WAIT — a strategically important turnaround that is genuinely happening, wrapped in a stock that has already priced the happy ending. The bull case is real and unusually structural: 18A is shipping, the US government is now an aligned ~10% owner, and Intel remains the only company outside Taiwan and Korea capable of leading-edge manufacturing at scale — optionality that, if it converts, is worth far more than today's price. But the panel's caution is equally concrete and, for now, decisive: the company still loses money, still burns cash, pays no dividend, and trades at north of 100x forward earnings and a ~$555B cap — while the analyst average target and every intrinsic-value estimate on the panel sit below the current quote, and the stock trades further above its 200-day than it did at the dot-com peak. What would tip the call decisively bullish is proof rather than promise — a Q2 print on July 23 showing 18A at profitable yields, a signed external 14A customer, and free cash flow turning positive. What keeps it a wait is that, until those arrive, buyers are paying a priced-for-perfection multiple for a business that hasn't yet earned it — the same strategic turnaround will be far more investable once the foundry economics, not the narrative, are doing the work.
contact@verdixhq.com · Published 2026-07-11 · Prices as of 2026-07-11 · Time horizon: 3–12 months · No direct position held in INTC · INTC verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call INTC yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Semiconductors / Foundry · 2026-07-18 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends revisit Intel after a three-week, 33% slide off its June high: the 18A turnaround story hasn't broken, but every lens on the panel is still tied to the same binary trigger — the July 23 print — with the stock now trading essentially on top of the analyst consensus target rather than below it. The debate and the key levels.Level to watch
Key resistance 100+5.2% from 95.04
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 95.04 (as of 2026-07-18)
What changed since 2026-07-11:
- Price: USD 109.84 → 95.04 (-13.5%) — three straight red weekly candles on rising volume, closing most of the gap between price and the analyst consensus target.
- Panel: 0 of 6 → 0 of 6 Bullish (unchanged in aggregate — still 4 Bearish / 2 Neutral), but the composition underneath shifted: The GARP Operator flipped Neutral → Bearish on the thin external-revenue proof and a now-unaffordable multiple, while The Disruptive-Innovation Seeker flipped Bearish → Neutral on fresh Microsoft/Amazon/Apple evaluation interest — a wash, with no lens turning bullish despite the drawdown.
- Trigger: The July 23 Q2 print — 18A yield economics, a signed external 14A customer, and free cash flow turning less negative.
- Verdict: WAIT (unchanged)
Nothing in the fundamentals has changed for the better: negative ROE (~-3%), negative operating margins, free cash flow around -$4.9B, and foundry external revenue still just ~$174M against a debt load north of $50B versus ~$21B of cash. The synthesis holds at WAIT because the price move closes a valuation gap without resolving the underlying question — every lens still ties its stance to the same July 23 trigger rather than calling the turnaround dead.
Key levels
Key levels · INTC
USD · as of 2026-07-18Analyst consensus target 101 USD · range 25–200
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance now starts at the recently broken $100 and $104 levels — last week's support, now overhead supply — with the June $142 swing high further above. Key support begins near $89.50, then the historical accumulation zone around the $84.50-85 weekly Supertrend line, where the trend structure has so far held. The analyst consensus target of $101 now sits essentially on top of the current price rather than comfortably above it, a much narrower gap than a week ago.
What legendary investors think
We ran Intel past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🔴 BearishHigh
Negative ROE, negative operating margins, and free cash flow around -$4.9B make this a business to avoid regardless of the 18A story, and a $95 quote sitting on top of a $101 consensus target says the market itself hasn't found a margin of safety. Foundry external revenue of just $174M against $50B+ of debt versus $21B cash is a balance sheet to avoid even with the government's ~9-10% equity stake as a backstop — better to watch through the July 23 print than guess on a coin-flip catalyst.
The GARP OperatorGrowth (GARP)🔴 BearishMedium
Still a turnaround, not a fast grower — negative ROE, negative operating margins, and ~$4.9B of annual cash burn against just $174M of external foundry revenue is thin proof the story is working, and a forward multiple near 90-100x on an unprofitable company isn't a computable PEG, it's a hope ratio. The Supertrend hasn't broken and the 18A ramp plus the government stake are real developments, but three red weekly candles on rising volume into a binary Q2 print is a setup better watched than owned into the news.
The Disruptive-Innovation SeekerGrowth⚫ NeutralLow
Intel sits at the convergence of AI compute and advanced manufacturing, with 18A shipping and evaluation interest from Microsoft, Amazon, and Apple signaling the platform bet is real, not incremental. But a negative TTM P/E, ~90-100x forward non-GAAP earnings, -3% ROE, and just $174M of external foundry revenue say the S-curve is still in its earliest innings — the Supertrend still holds near $85, so the multi-year thesis isn't dead, but the panel stays on the sidelines until 18A yields, signed external customers, and positive free cash flow turn the platform bet into platform economics.
The Intrinsic-Value ModelerValuation🔴 BearishMedium
Every valuation tells a story, and Intel's is still a turnaround trading at a growth-stock multiple — 90-100x forward non-GAAP earnings on a business with -3% ROE, negative operating margins, and roughly -$4.9B of free cash flow. The $95.04 price sitting essentially on the $101 analyst consensus average is misleading comfort — that average spans $25 to $200, a dispersion that signals genuine uncertainty rather than a bullish tell, and with foundry external revenue at just ~$174M, the panel wants to see 18A yields and signed external customers before paying up.
The Forensic SkepticContrarian🔴 BearishMedium
The filings still show a company burning cash — negative operating margin, roughly -$4.9B free cash flow, -3% ROE, and only ~$174M of external foundry revenue — trading at 90-100x a forward non-GAAP number that assumes a turnaround not yet in evidence. The market is starting to price that gap: three straight red weekly candles and a 33% drawdown from the June $142 high, with the $101 consensus target only now catching up to the $95.04 quote; the Supertrend hasn't flipped and $85 support is intact, so this is a name to watch through the binary July 23 print rather than one with a margin of safety today.
The Macro OpportunistMacro⚫ NeutralLow
Three straight red weeks, down 33% off the June high on rising volume, is distribution, not noise — that kind of technical damage argues for caution regardless of the story. But the weekly Supertrend hasn't flipped and price is still holding the $84.50-85 trend line, so the panel isn't committing capital either direction until it sees how the stock trades through the $89.50 support and the July 23 print, at 90-100x forward non-GAAP earnings with the analyst target only now catching up to the price.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Fundamentals remain weak: negative ROE (~-3%), negative operating margins, free cash flow around -$4.9B, and foundry's external revenue still tiny at ~$174M.
- Valuation is rich for an unprofitable business: 90-100x forward non-GAAP earnings, with the $95.04 price now sitting essentially on top of the $101 analyst consensus average rather than comfortably below it.
- The technical picture has weakened — three straight red weekly candles and a 33% drawdown from the June $142 high on rising volume — but the weekly Supertrend / trend line near $84.50-85 has so far held.
- The July 23 Q2 print is the decisive near-term catalyst: 18A yields, signed external 14A customers, and a path to positive free cash flow are all still unproven.
The real debate
- Is the pullback overdone or overdue? The Macro Opportunist and Disruptive-Innovation Seeker read the intact Supertrend as a reason not to chase the move in either direction, while the Forensic Skeptic and Intrinsic-Value Modeler see the drawdown as the market finally re-pricing a gap that was always there.
- Does the platform bet justify the multiple? The Disruptive-Innovation Seeker points to fresh evaluation interest from Microsoft, Amazon, and Apple as evidence the 18A story is real, while the Moat Compounder weighs foundry's ~$174M of external revenue against $50B+ of debt and concludes the balance-sheet risk outweighs the optionality.
- How much does the government stake help? Read as a strategic backstop for the business by most of the panel, but not enough on its own to offset the cash burn for the Moat Compounder.
The question it comes down to: Is the 33% slide off the June high the market catching up to an unprofitable turnaround that hasn't yet proven itself, or a shakeout within an intact uptrend ahead of a binary July 23 print that could validate the 18A story?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 95.04 / n/a |
| P/E (TTM / fwd) | Negative (TTM net loss) / ~90-100x non-GAAP |
| ROE | ~-3% |
| Operating margin | Negative |
| Dividend yield | Suspended (since Q4 2024) |
| Debt / equity | n/a (debt >$50B vs ~$21B cash) |
| Free cash flow | ~-$4.9B |
Figures as of Q1 2026 (reported Apr 2026) / July 18, 2026; sourced from Intel IR/SEC filings and the panel's fundamentals review, carried forward from the prior analysis (2026-07-11). Foundry external revenue was ~$174M in Q1 (still a tiny paying-customer base); 18A is shipping, with fresh evaluation interest reported from Microsoft, Amazon, and Apple foundry customers, though 14A depends on external customers not yet signed. The US government holds a 9-10% equity stake from converted CHIPS funding. Analyst consensus ($101 avg, range ~$25-200) now sits essentially on the price rather than below it. Next print: July 23, 2026 (Q2 2026).
The bottom line
What keeps this at WAIT rather than tipping toward SELL is that every one of the six lenses — even the bearish ones — ties its caution to the same near-dated trigger rather than declaring the business broken outright, and the weekly Supertrend / $84.50-85 trend line has so far held through the drawdown. What would tip the call decisively bullish: the July 23 print showing 18A at profitable yields, a signed external 14A customer, and evidence the fresh Microsoft/Amazon/Apple evaluation interest is converting to revenue rather than just interest. What would tip it bearish: a Supertrend break below $84.50-85 alongside a print showing cash burn worsening rather than improving. Until one of those resolves, this stays a turnaround whose stock price has largely caught up to the story — watched through the print, not acted on ahead of it.
contact@verdixhq.com · Published 2026-07-18 · Prices as of 2026-07-18 · Time horizon: 3–12 months · No direct position held in INTC · INTC verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call INTC yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Semiconductors / Foundry · 2026-07-25 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
The binary July 23 catalyst the panel spent two weeks waiting on has now fired — and the market's verdict on it was a violent round trip, not a clean resolution. Intel beat on revenue, margin, and yield, then gave almost all of it back on a capex-guidance shock, leaving the panel split 2 Bearish / 4 Neutral / 0 Bullish and the price essentially flat-to-lower on the week. The debate and the key levels.Level to watch
Key support 89.5−3.1% from 92.32
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 92.32 (as of 2026-07-25)
What changed since 2026-07-18:
- Price: USD 95.04 → 92.32 (-2.72, -2.86%) — but the path there was not a straight line: the stock gapped as much as ~13% higher after the July 23 print, spiked intraweek toward $106.85, then reversed hard and closed down 7.9% on Friday July 25, ending net below last week's close despite the best quarterly growth print in 15 years.
- Panel: 4 Bearish / 2 Neutral / 0 Bullish → 2 Bearish / 4 Neutral / 0 Bullish. The Moat Compounder eased Bearish High → Bearish Medium on genuine operating-leverage evidence; The GARP Operator flipped Bearish → Neutral as 18A yields and a signed external customer landed; The Intrinsic-Value Modeler flipped Bearish → Neutral on the same proof points. The Forensic Skeptic held Bearish, flagging a widened GAAP loss. No lens moved to Bullish.
- Catalyst: The binary July 23 Q2 print is now resolved, not pending — revenue $16.13B (+25% YoY, fastest growth in 15+ years), gross margin back above 40% for the first time in two years, 18A yield jumped to roughly 85% from 65%, and Intel landed its first named external foundry customers (Fortinet, a hyperscaler manufacturing deal).
- New risk / offset: 2026 capex guidance was raised from $18B to over $20B, with 2027 flagged as "significantly higher" still — a fresh overhang the market punished harder than it credited the beat. Foundry still posted a ~$2.1B operating loss for the quarter, and external foundry revenue, while nearly doubling to ~$293M, remains under 2% of total sales.
- Verdict: WAIT (unchanged)
The trigger this whole panel was waiting on fired, and it delivered real evidence on two of the three proof points flagged last week — yield economics and a signed external customer — while the third, a clear path to positive free cash flow, stayed muddled: operating cash flow turned sharply positive for H1, but capex intensity rose in the same breath, and at least one panel lens reads the underlying cash burn as having widened, not narrowed, once GAAP and adjusted figures are reconciled. The market's own reaction — a violent intraday round trip that erased the post-earnings pop by Friday — is itself evidence that this print didn't settle the debate, it just moved it forward a quarter. With the panel now 2 Bearish / 4 Neutral and zero lenses willing to call this Bullish, and price still testing the same $89.50 support rather than reclaiming resistance, the case for waiting through one more data point (Q3, October 22) outweighs the case for acting on this one.
Key levels
Key levels · INTC
USD · as of 2026-07-25Analyst consensus target 101 USD · range 25–200
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Resistance starts at the psychological $100 level — directly rejected this week (07-24 high 101.74) — with the band above widened to $104-107 after a wick to $106.85 was fully rejected back to the close, and the June $142 all-time high still far overhead. Support held at $89.50, tested almost exactly (07-13 low 89.59) and defended, with price basing just above it for two straight weekly closes. The critical line remains the $84.50-85 historical accumulation zone / weekly Supertrend, still untested this cycle; a break below it would open a much deeper, speculative $68-70 zone last seen before the parabolic run to $142 began. The analyst consensus band widened this week as multiple desks raised targets post-print (as high as $155) while others trimmed (as low as $85), so the dispersion itself — not just the average — is the signal: genuine disagreement, not consensus.
What legendary investors think
We ran Intel past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🔴 BearishMedium
The print showed real operating leverage — non-GAAP operating margin swung positive and external foundry revenue moved from $174M to $293M, "enough evidence the patient can still walk, it doesn't tell me the patient is cured." The debt load (north of $50B against ~$21-30B cash) is untouched by one good quarter, and "I'd rather pay up for a proven wonderful business than bet on a good quarter turning into a good decade."
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
18A yields jumped from 65% to 85% and Fortinet turned evaluation interest into a real signed customer, while revenue grew 25% YoY — genuine proof, not just story. But "you don't get to call cash burn 'improving' while raising capex guidance in the same breath — that's still a hope ratio, just a better-dressed one," with foundry still losing $2.1B against DCAI's $2.5B profit.
The Disruptive-Innovation SeekerGrowth⚫ NeutralLow
A named 18A customer plus a hyperscaler manufacturing deal and yield climbing to ~85% is the S-curve inflecting, not stalling — but "doubling from a rounding error is still a rounding error," with external revenue still under 2% of sales and an ~$11B net loss in the same quarter. Staying on the sidelines with attention, not conviction, until external revenue moves from hundreds of millions to billions.
The Intrinsic-Value ModelerValuation⚫ NeutralMedium
Signed external customers and the yield jump are real inputs moving off Bearish — but capex guidance rising to $20B+ while foundry still bled $2.1B pushes the reinvestment math the wrong way: "growth without a shrinking reinvestment rate is just a bigger number to discount, not more value." Watching one more quarter of capex-to-external-revenue conversion before calling the wider discount to consensus a bargain.
The Forensic SkepticContrarian🔴 BearishMedium
Read past the non-GAAP headline: GAAP EPS came in at -$2.16, a wider loss than last quarter, while adjusted free cash flow burn nearly doubled to roughly -$8.4B even as revenue grew. "A revenue beat that comes with a doubled cash burn isn't a turnaround, it's a more expensive way of not turning around," with external foundry revenue still a rounding error against $50B+ of debt.
The Macro OpportunistMacro⚫ NeutralLow
A genuinely good print sold off hard on capex-overhang fear rather than bounced — "when the fundamentals get better and the stock keeps going down, that's the market telling you something you don't know yet — listen to it, don't argue with it." The $84.50-85 trend line still hasn't broken, so not selling into weakness that isn't confirmed, but not buying a print this good getting this little credit either.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The July 23 print delivered genuine operating-quality improvement: revenue +25% YoY (fastest in 15+ years), gross margin above 40% for the first time in two years, 18A yield up from ~65% to ~85%, and the first named external foundry customers.
- External foundry revenue nearly doubled ($174M → $293M) and 18A traction is real — but still tiny in absolute terms against a $50B+ debt load and a foundry segment still losing money.
- The raised 2026-27 capex guidance is a new overhang that emerged only this week, and it's what the market punished, not the underlying beat.
- The $89.50 support held and the $84.50-85 trend line remains unbroken — the technical picture has not confirmed a deeper breakdown, even after a volatile week.
- No lens is willing to call this Bullish yet; the debate has moved from "is the story dead" to "how much does the capex bill for keeping it alive matter."
The real debate
- Is cash generation actually improving or getting worse? The Forensic Skeptic points to a wider GAAP loss (-$2.16 EPS) and adjusted free cash flow burn nearly doubling to ~-$8.4B, while other lenses cite H1 operating cash flow turning sharply positive (+$8.1B) — the same quarter reads oppositely depending on which cash metric anchors the argument.
- Does rising capex validate the platform bet or undermine it? The GARP Operator and The Intrinsic-Value Modeler treat $20B+ capex against a still-losing foundry as reinvestment math getting worse; The Disruptive-Innovation Seeker and The Macro Opportunist read it as the necessary cost of an inflecting yield curve, not a red flag on its own.
- Should the market's negative reaction to a beat override the fundamentals? The Macro Opportunist treats the sell-off itself as the signal worth respecting regardless of the print's quality; the valuation-focused lenses are more willing to look through one volatile week to the underlying trend.
The question it comes down to: Is the July 23 print the start of a credible margin and yield inflection the market hasn't caught up to yet, or a genuinely good quarter bought at an escalating capex cost that the stock's own reversal is already pricing in?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 92.32 / n/a |
| P/E (TTM / fwd) | Negative (GAAP EPS -$2.16, incl. a non-cash CHIPS-Act mark-to-market charge) / ~90x non-GAAP |
| ROE | ~-10.72% TTM (vs. ~-3% cited 2026-07-18; swing driven largely by the one-time GAAP charge, not core operations) |
| Operating margin | Non-GAAP swung positive (~17.2%); GAAP still negative — foundry posted a ~$2.09B operating loss in Q2 |
| Dividend yield | Suspended (since Q4 2024) |
| Debt / equity | n/a (debt ~$50.5B vs. ~$29.7B cash; net debt ~-$20.8B) |
| Free cash flow | Diverging reads: H1 operating cash flow +$8.1B (a reversal from the prior -$4.9B FCF baseline), but adjusted FCF burn is separately reported as having widened to ~-$8.4B — metric definitions differ; watch for confirmation next quarter |
Figures as of Q2 2026 (reported July 23, 2026) / July 25, 2026; sourced from Intel IR/SEC filings, CNBC (2026-07-23/24), GuruFocus/StockAnalysis (2026-07-24), and ts2.tech (2026-07-25), cross-referenced against the panel's fundamentals review. External foundry revenue was ~$293M in Q2 (up from ~$174M in Q1), still under 2% of total foundry sales; 18A yield reported around 85%, up from ~65%. Analyst targets moved in both directions post-print (KeyBanc to $155, Seaport to $125, Wells Fargo to $120, Wedbush to $98, JPMorgan to $85), widening dispersion versus the prior ~$101 average. Next print: October 22, 2026 (Q3 2026).
The bottom line
What keeps this at WAIT rather than tipping toward BUY is that the panel's own proof points — the yield jump, the signed external customers, the margin inflection — arrived alongside a capex bill that got materially bigger in the same print, and the market's violent round trip suggests investors are still arguing about which one dominates. What keeps it from tipping toward SELL is that two lenses moved off Bearish this week on real evidence, not sentiment, and the $84.50-85 trend line has still not broken. What would tip the call decisively bullish: a Q3 print (October 22) showing external foundry revenue moving from hundreds of millions toward billions, foundry losses narrowing rather than widening against the new capex base, and free cash flow definitions converging on an actual improving trend. What would tip it bearish: a weekly close below $84.50-85, or a Q3 print showing the capex increase outpacing any narrowing in foundry losses. Until one of those resolves, this stays a turnaround with real green shoots trading through a market that isn't ready to reward them yet.
contact@verdixhq.com · Published 2026-07-25 · Prices as of 2026-07-25 · Time horizon: 3–12 months · No direct position held in INTC · INTC verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against INTC — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Information Technology · 2026-08-01 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellHIGH confidence
Why
Six investing archetypes — spanning value, forensic, macro, moat, GARP, and activist frameworks — unanimously reject Intel at $90, citing a broken business model with negative GAAP earnings, $20B+ in annual capex consuming all cash flow, insider selling, and a forward P/E near 90x. The debate isn't whether to buy but how far the stock could fall before value emerges, with intrinsic-value estimates clustering between $40 and $60.Level to watch
Key resistance 94.15+4.4% from 90.2
The panel's take
Verdict: SELL · Conviction: HIGH · Last price: USD 90.2 · Changed from WAIT
What changed since 2026-07-25:
- Price: 92.32 → 90.2 (-2.30%)
- Panel: 0 of 6 → 0 of 6 now Bullish — composition also changed: added The Activist Catalyst; removed The Disruptive-Innovation Seeker
- Trigger: BUY trigger: GAAP profitability with positive free cash flow, a named marquee external foundry customer (Nvidia/Apple/AMD) with multi-year volume commitments, and insider buying resumes. Alternatively, price below $50 would provide enough margin of safety for The Forensic Skeptic/The Moat Compounder frameworks to reconsider. Breakdown trigger (reinforces SELL): equity dilution of 5%+, 2027 capex guidance above $25B, or a weekly close below $80.01 confirming Stage 3 topping.
- Verdict: WAIT → SELL
The prior WAIT verdict rested on a panel that included The Disruptive-Innovation Seeker, whose framework could tolerate long-duration, unprofitable growth stories if the technology thesis was compelling. Replacing that voice with The Activist Catalyst — whose framework demands management alignment, simple predictable businesses, and immediate free cash flow — removes the last potential bull case from the room. Combined with the CFO's newly public refusal to rule out equity dilution, the panel's center of gravity shifted decisively from "wait for confirmation" to "the business itself is broken at this valuation," converting a cautious WAIT into a high-conviction SELL.
This is not a BUY vs WAIT split — zero voices are bullish. The two WAIT recommendations (technical-scout, fundamental-scout) are themselves qualified by deep business concerns (no proven moat, negative ROE, bearish weekly breakdown). The six Bearish voices — The Moat Compounder, The Activist Catalyst, The Forensic Skeptic, The Macro Opportunist, The GARP Operator, and The Intrinsic-Value Modeler — each articulate structural objections to the business itself: negative GAAP earnings, $20B+ annual capex consuming all operating cash flow, no durable competitive advantage, insider selling with zero purchases, and a forward P/E of ~90x. The WAIT camp's trigger (weekly close above $94.15) is irrelevant when the business case is broken at current valuation. When every cautious voice objects on BUSINESS grounds and the most conservative valuation (The Forensic Skeptic: $40–55 weighted intrinsic value) implies 40–55% downside from $90, the appropriate verdict is SELL — not HOLD, which would imply a balanced business debate that does not exist here.
Key levels
Key levels · INTC
USD · as of 2026-08-01Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Intel past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: Intel's forward P/E of ~90x and enterprise value of ~$392B price in a flawless turnaround, yet the sum-of-the-parts fair value lands near $300B–$330B — roughly 15–20% below the current price — and until depreciation catches up to capital spending, the business remains deeply free-cash-flow negative. Conviction: Conviction is held at 65% rather than higher because 18A yields at 85% and a 25% revenue beat in Q2 2026 represent real operational progress, creating a non-trivial possibility that a marquee external foundry customer could close the narrative-versus-numbers gap before the market reprices the stock.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: Insiders have sold $4 million of stock in the past 90 days with zero purchases, the CFO refuses to rule out equity dilution at $90, and the weighted intrinsic value of $40–55 implies 40–55% downside from current levels — there is no margin of safety anywhere near this price. Conviction: Conviction is elevated by multiple independent indicators — 16.8% share-count dilution over the past year, a 20+ point gap between non-GAAP operating margin (12.3%) and GAAP operating loss (-9.45%), negative ROE and ROIC, and insider behavior — that converge on the same conclusion without relying on any single contested assumption.
The Macro OpportunistMacro/Timing🔴 BearishMed
Signal: With the Fed still draining ~$60B/month in liquidity, bank reserves declining, and Intel requiring $20B+ in annual capex with negative free cash flow, the macro environment is actively hostile to a 90x P/E turnaround and the weekly chart confirms the damage with a bearish MACD crossover and price stuck below the 20-week EMA at $94.15. Conviction: Conviction is reinforced by the rare alignment of macro, fundamental, and technical signals — QT draining liquidity, a punishing 33% post-earnings decline on heavy volume, and insiders selling — where any one signal alone would warrant caution but all three together make the bearish case unusually robust.
The Moat CompounderValue/Quality/Moat🔴 BearishHigh
Signal: A moat score of 17 out of 100, negative GAAP margins, and negative ROE of -2.95% signal a commodity business without durable competitive advantage, and paying 90x forward earnings for a company currently losing money offers zero margin of safety under any framework that requires a wonderful business at a fair price. Conviction: Conviction reaches 90% because the business fails on every criterion simultaneously — understandable, moated, financially healthy, well-managed, and fairly valued — creating an unambiguous pass that does not depend on any narrow forecast about foundry execution.
The GARP OperatorGrowth (GARP)🔴 BearishMed
Signal: Intel is a classic high-risk turnaround with no clear path to recovery — 89x forward earnings for a cyclical semiconductor company with negative ROE and $45B in debt — and the $4M in insider sales with zero purchases tells you the people running the business aren't betting on the story either. Conviction: Conviction is tempered mainly by the possibility that a named external foundry customer could transform the narrative, but the combination of negative GAAP earnings, deeply negative free cash flow, and a CFO openly entertaining dilution keeps the bearish case on firm footing without relying on that single unresolved dependency.
The Activist CatalystActivist/Capital Allocation🔴 BearishHigh
Signal: With insiders owning just 0.05% of the company, 21% share-count dilution over four years, and the CFO openly discussing equity sales, management has demonstrated virtually zero alignment with shareholders while the foundry strategy remains an unproven binary bet that could take until 2028 or beyond to validate. Conviction: Conviction is near-maximum because the bearish case rests on multiple structural facts — no moat, negative free cash flow, terrible capital-allocation history, extreme valuation — that do not depend on any single forecast about customer wins or node yields, making the thesis resilient to any one variable moving favorably.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six voices agree Intel lacks a durable competitive advantage today — the moat score of 17/100, negative ROE, and loss of manufacturing leadership to TSMC are undisputed.
- Every archetype flags the valuation as extreme: a forward P/E of ~90x for a company with negative GAAP earnings and negative free cash flow is untenable across frameworks.
- Insider behavior is universally cited as a red flag — $4M in sales, zero purchases, 0.05% insider ownership, and the CFO's openness to equity dilution signal management does not believe the stock is undervalued.
- All analyses point to the same condition that would change the bearish view: a named marquee external foundry customer with multi-year volume commitments, combined with a path to GAAP profitability and positive free cash flow.
- The $20B+ annual capex burden consuming all operating cash flow is seen by every voice as the central structural problem — without it, the business case would look entirely different.
The real debate
- The Intrinsic-Value Modeler sees fair value around $300B–$330B (15–20% downside), while The Forensic Skeptic calculates weighted intrinsic value at $40–55 per share (40–55% downside) — a disagreement not about direction but about the magnitude of overvaluation, driven by different assumptions about how much credit to give the turnaround in a sum-of-the-parts framework.
- The Macro Opportunist emphasizes that the weekly chart can heal with a close above $94.15, opening the door to a tactical reassessment, while The Moat Compounder and The Activist Catalyst see the technical picture as irrelevant next to the structural business deficiencies — a tension between those who might flip on price action alone and those who require fundamental business proof.
- The GARP Operator frames Intel as a turnaround stock where a ten-bagger is theoretically possible if foundry succeeds, while The Activist Catalyst dismisses the same scenario as a binary bet no rational investor should take — a genuine disagreement about whether the asymmetry of a turnaround story ever justifies exposure at the current price.
The question it comes down to: Can Intel secure a marquee external foundry customer with multi-year volume commitments and demonstrate a credible path to GAAP profitability and positive free cash flow before the capital-spending burden — $20B+ annually and potentially rising — forces equity dilution that permanently impairs existing shareholders?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 90.2 / n/a |
| P/E (TTM / fwd) | -152.4x (negative TTM earnings) / 89.4x (FY2026 consensus) |
| ROE | -2.95% (TTM) |
| Operating margin | -9.45% (GAAP, TTM) |
| Dividend yield | n/a |
| Debt / equity | 0.09–0.40 (source-dependent) |
| Free cash flow | Negative (P/FCF -155.1x; exact $ figure n/a) |
Figures as of August 1, 2026; sourced from Trefis (July 2026) and Kaplio (data gathered 2025-08-10, stale for balance-sheet figures) via fundamental-scout analysis.
The bottom line
The single condition that would flip this call from SELL to BUY is GAAP profitability with positive free cash flow, paired with a named marquee external foundry customer under multi-year volume commitments — watch for any announcement involving Nvidia, Apple, or AMD committing to 14A or 18A at scale. On the downside, a weekly close below $80.01 would confirm Stage 3 topping and open a path toward the $55–65 range where value frameworks would begin to engage. The 2027 capex guidance — expected in the next earnings cycle — is the nearest dated catalyst: a figure above $25B would validate every bearish concern about the cash furnace, while a figure below $18B with a clear FCF-inflection timeline would challenge the consensus view. Insider buying resuming at current levels would be an immediate positive signal; continued selling into any rally should be read as confirmation that those closest to the numbers see no floor yet.
contact@verdixhq.com · Published 2026-08-01 · Prices as of 2026-08-01 · Time horizon: 3–12 months · No direct position held in INTC · INTC verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against INTC — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Information Technology · 2026-08-08 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellHIGH confidence
Why
A panel of six investing archetypes dissects Intel at $101 after a 460% rally from its lows. The AI data center surge is real, but negative GAAP earnings, value-destroying returns on capital, insider selling, and a 60x forward P/E leave the panel split between bearish and neutral. Not a single bullish voice is willing to defend the current price.Level to watch
Key support 95.69−5.9% from 101.65
Next catalyst
GAAP profitability trigger: Two consecutive quarters of positive GAAP net income (starting with Q3 2026 guidance of $0.38 EPS) would shift the debate from hope to evidence and could flip neutral voices to bullish.The panel's take
Verdict: SELL · Conviction: HIGH · Last price: 101.65
What changed since 2026-08-01:
- Price: 90.2 → 101.65 (+12.69%)
- Panel: 0 of 6 → 0 of 6 now Bullish — composition also changed: added The Disruptive-Innovation Seeker, The Quality Rationalist; removed The Macro Opportunist, The Moat Compounder
- Trigger: Two consecutive quarters of GAAP profitability with ROIC climbing above 10% and a credible external foundry customer win at scale (e.g., Apple, Microsoft, NVIDIA). Alternatively, a pullback below $50 would price in the genuine execution risk and could flip the balance of upside versus downside to BUY for deep-value investors — but not before.
- Verdict: SELL (unchanged)
The stock rose roughly 13% since the prior SELL call, yet the fundamentals have not improved to match: the higher price only stretches an already demanding valuation further above every neutral voice's intrinsic-value range. The replacement of two panelists with The Quality Rationalist and The Disruptive-Innovation Seeker added fresh bearish analysis on business-quality and innovation-economics grounds, reinforcing the original verdict without introducing a single new bullish counterweight.
This is a BUSINESS-dominant split, not PRICE/TIMING. The cautious camp (The Forensic Skeptic, The Activist Catalyst, The Quality Rationalist, and elements of The Intrinsic-Value Modeler/The GARP Operator) object to the company itself: negative GAAP earnings, ROIC deeply below WACC, a narrowing moat, insider selling, and a forward P/E of 60x that prices in perfection. There is no "great business, wrong price" faction; even the neutral voices (The Intrinsic-Value Modeler, The GARP Operator) put intrinsic value well below $101. HOLD would be wrong because the bearish case dominates the fundamentals. This isn't a standoff; it's one side holding the weight of evidence. WAIT would be wrong because no cautious voice is saying "I love the business, I just want a cheaper entry." The lone bullish voice (technical-scout) is itself half-HOLD and acknowledges deteriorating momentum.
Key levels
Key levels · INTC
USD · as of 2026-08-08Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Intel past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralLow
Signal: At 8.92x revenue and a 60x forward P/E, <strong>the market is already pricing in a best-case turnaround</strong>, yet GAAP operating margins remain negative and ROIC sits at 3.42%, nearly 12 points below the 15.24% cost of capital. Conviction: The gap between improving adjusted margins (17.2%) and deeply negative GAAP profitability creates a dependency on non-cash charges resolving: a single contested assumption that swings intrinsic value by roughly $40 between the bear and bull cases.
The GARP OperatorGrowth (GARP)⚫ NeutralMed
Signal: The PEG ratio of 0.76 looks deceptively cheap, but <strong>with negative trailing GAAP earnings, you are buying a story, not a business</strong>, and the forward P/E of 60x prices in a recovery that has not materialized yet. Conviction: Multiple red flags ($6.5M in net insider selling, a forward P/E of 60x, and thin volume above $90) hold conviction firmly in check, even though the genuine 59% data center revenue surge keeps this from being a clean bearish call.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: Intel trades at 5.8x book, 8.9x sales, and 180x free cash flow while <strong>ROIC of 3.4% against a 15.2% WACC confirms this is a value-destruction machine, not a growth story</strong>, and the $6.5M in net insider selling tells you the people closest to the P&L agree. Conviction: Five independent, hard-to-dispute facts (negative GAAP net margin, sub-WACC ROIC, stretched multiples, insider selling, and a weekly MACD bearish crossover) all point the same direction, leaving no single contested assumption that could break the bearish thesis.
The Activist CatalystActivist/Capital Allocation🔴 BearishMed
Signal: Annual capex of $18B and $20B of net debt are destroying capital, not creating it, with ROIC stuck at 3.4% even as the market pays 9x sales and 60x forward earnings for the turnaround story. <strong>That combination makes this a stock for momentum traders, not a principled investment for value investors</strong>, and the FCF yield of just 0.6% confirms there's little cash actually backing the multiple. Conviction: Weak management alignment (low insider ownership, with executives selling at $118) and zero proven external foundry customers make the turnaround thesis dependent on assumptions that have not been validated, capping conviction on any bullish scenario.
The Quality RationalistMental Models/Quality🔴 BearishMed
Signal: The x86 moat is narrowing as TSMC extends its manufacturing lead, and the balance sheet confirms it: <strong>negative ROE of -10.72% and ROIC of 3.42% versus 15.24% WACC mean Intel is destroying wealth with every dollar invested</strong>, and even a lemonade stand earns better returns on capital than that. Conviction: What tips this into the 'too hard' pile is convergence, not any single number: the psychology of AI-narrative euphoria, the economics of scale favoring TSMC, and an inversion test showing multiple paths to permanent capital loss all point the same way.
The Disruptive-Innovation SeekerDisruptive Innovation⚫ NeutralLow
Signal: Data center revenue surged 59% and AI demand is supply-constrained, but <strong>Intel is a capital consumer, not a capital compounder</strong>. With ROIC at 3.4% versus 15.2% WACC, the foundry strategy is structurally inverted, and the base-case 5-year target of $85 sits below today's $101 price. Conviction: Wright's Law works against Intel: TSMC's cumulative volume advantage means Intel must re-enter a learning curve it abandoned, and until a major external foundry customer validates the platform economics, the S-curve remains hypothetical, holding conviction at just 45%.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six archetypes acknowledge the AI data center tailwind is genuine: data center revenue up 59% is not in dispute.
- All agree the valuation is stretched at roughly 60x forward earnings and 9x sales, pricing in a recovery that has not yet arrived in GAAP numbers.
- All flag ROIC (3.4%) running far below WACC (15.2%) as a fundamental problem: the business currently destroys capital.
- All note the $6.5M in net insider selling over 90 days as a signal that merits attention, not dismissal.
- All concur the foundry strategy remains unproven: no external customer at scale exists today.
The real debate
- The Disruptive-Innovation Seeker sees the Secure Enclave government partnership and 14A process as a potential S-curve inflection worth monitoring, while The Forensic Skeptic values the foundry at zero in a sum-of-parts framework and calls it a cash incinerator. The core debate is whether the foundry is an option worth something or a liability destroying the enterprise.
- The Intrinsic-Value Modeler estimates fair value at $85–95 (modest 6–16% downside), while The Forensic Skeptic pegs intrinsic value at $45–55 (massive 45–55% downside), a $40 gap driven entirely by assumptions about normalized earnings power and whether the data center surge is structural or cyclical.
- The GARP Operator would become interested on a pullback to the $85–90 historical accumulation zone, while The Quality Rationalist would require two full years of ROIC above 10% before even considering the stock: a tension between price-sensitive entry and proof-of-turnaround entry.
The question it comes down to: Can Intel produce two consecutive quarters of GAAP profitability and land a credible external foundry customer at scale before the heavy capex burden, TSMC's insurmountable manufacturing lead, and a 60x forward P/E close the window on this turnaround?
The bottom line
- GAAP profitability trigger: Two consecutive quarters of positive GAAP net income (starting with Q3 2026 guidance of $0.38 EPS) would shift the debate from hope to evidence and could flip neutral voices to bullish.
- Foundry customer catalyst: A credible external foundry win at scale (Microsoft, Apple, or NVIDIA) would validate the platform economics and force even the bearish camp to reprice the foundry from zero to something material.
- Key support to hold: A weekly close below $95 (the monthly 38.2% Fibonacci retracement and the weekly EMA20) would confirm the bearish MACD crossover and likely accelerate selling toward $80.
- Q3 earnings bar: Guidance of $15.8–16.8B revenue sets a high bar; any miss would be the first crack in the AI-demand narrative and a catalyst for repricing toward the Forensic Skeptic's $45–55 intrinsic value range.
- ROIC milestone: ROIC climbing above 10% (from 3.4% today) would be the first hard evidence the turnaround is creating rather than destroying capital, the single metric The Quality Rationalist and The Activist Catalyst both name as non-negotiable.
contact@verdixhq.com · Published 2026-08-08 · Prices as of 2026-08-08 · Time horizon: 3–12 months · No direct position held in INTC · INTC verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call INTC yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Information Technology · 2026-08-15 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Intel's stock divides the panel between those who see structural business decay and those who see a turnaround that is merely too expensive at $102.50. The verdict lands at WAIT: the Q2 operational beat is real, but every framework agrees the foundry pivot remains an unproven binary bet priced for perfection, and a pullback to the $95-97 support zone is the specific trigger that would change the math.Level to watch
Key support 96.67−5.7% from 102.5
Next catalyst
Trigger to flip bullish: A weekly close above $115 resistance on expanding volume, ideally paired with a marquee foundry customer announcement for the 18A node, would confirm the correction is over and the Stage 2 uptrend is resuming.The panel's take
Verdict: WAIT · Conviction: MED · Last price: 102.5 · Changed from SELL
What changed since 2026-08-08:
- Price: 101.65 → 102.5 (+0.84%)
- Panel: 0 of 6 → 0 of 5 now Bullish — composition also changed: added The Macro Opportunist; removed The Activist Catalyst, The Disruptive-Innovation Seeker
- Trigger: BUY on a pullback to $95-97 with a bullish reversal candle and weekly MACD histogram flattening/turning up, OR on announcement of a marquee foundry customer (NVIDIA, AMD, or major hyperscaler) for 18A node. SELL if price breaks below $95 on expanding volume, confirming the correction has further to run toward $80-85 and signaling the turnaround premium is unwinding.
- Verdict: SELL → WAIT
The prior panel (Aug 8) issued a unanimous SELL at $101.65, driven by a lineup weighted toward intrinsic-value and quality frameworks that saw no margin of safety at any nearby price. Today's panel removes the Activist Catalyst and Disruptive-Innovation Seeker and adds the Macro Opportunist, shifting the split from unanimous bearishness to a PRICE/TIMING-dominant WAIT: two voices remain structurally bearish, but three others now see a tradable setup if price pulls into the $95-97 zone. The verdict moves from SELL to WAIT not because the business improved materially in seven days, but because the panel's composition now includes voices that frame the objection as "wrong price" rather than "broken business," and that distinction opens a specific entry level where the call flips.
Despite two genuine SELL/Bearish voices citing structural business deterioration (negative ROE, negative ROIC, declining revenue, damaged moat), the dominant split is BUY-vs-WAIT: the bulls (sentiment-scout, The GARP Operator's operational evidence) acknowledge real Q2 momentum but every cautious voice — including the value-oriented ones — frames the objection as "decent story, wrong price." No voice with an actionable BUY at today's $102.50. The structure is a PRICE/TIMING-dominant split with a specific trigger: a pullback into the $95-97 support zone (weekly EMA20 + 38.2% Fib) where the balance of upside to downside flips to favorable. That makes this a classic WAIT, not a BALANCED — price is the single blocker, and a specific lower entry level is identified.
Key levels
Key levels · INTC
USD · as of 2026-08-15Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Intel past a panel of 5 legendary investors' frameworks.
The panel · 5 investors
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed
Signal: DCF modeling yields an intrinsic value of $115, implying 12% upside, but that return is too thin given the binary nature of the foundry pivot: the bear case ($65, a 37% drop) sits far closer than the bull case ($155) if 14A/18A delays surface or a second marquee customer fails to commit. Conviction: Conviction is held in check by one dependency: the entire base case assumes 15% revenue CAGR and margin recovery to 20%, and without a tangible foundry customer beyond Fortinet, those assumptions rest on hope rather than evidence.
The Forensic SkepticContrarian/Forensic⚫ NeutralMed
Signal: The balance sheet tells the real story: $50.5 billion in debt, negative ROIC at -0.07%, and debt-to-FCF at 17.85x, meaning Intel is levering up to fund a turnaround whose earnings quality is masked by a widening chasm between GAAP net losses and adjusted EPS. Conviction: Conviction stays guarded because the Q2 revenue beat is the only bright spot in an otherwise deteriorating fundamental picture, and until the footnotes confirm that beat was organic demand rather than channel stuffing, the bull case is built on one unverified quarter.
The Quality RationalistMental Models/Quality🔴 BearishMed
Signal: The moat has collapsed from wide to narrow: gross margins fell from 60%+ to 38.87%, ROE swung from +22.52% to -10.72%, and Intel is spending $50 billion it does not earn to chase a competitor that already owns the manufacturing lead. Conviction: Conviction is firm because the deterioration spans every quality metric simultaneously — margins, returns on capital, balance sheet strength, competitive position — which is the pattern of structural decline, not a temporary dip.
The GARP OperatorGrowth (GARP)⚫ NeutralLow
Signal: The Q2 2026 quarter delivered genuine operational evidence: revenue grew at its fastest pace since 2011, foundry sales hit $5.8 billion (up 31%), and management openly stated they are supply-constrained, which is the kind of real-world data point I hunt for in a turnaround. Conviction: Conviction stays low because the forward P/E of 52-63x prices in the entire foundry success story before a single marquee customer has signed on, and a PEG ratio of 0.91 built on analyst projections of 46% EPS growth from a nonexistent base is the most dangerous kind of valuation mirage.
The Macro OpportunistMacro/Timing⚫ NeutralMed
Signal: The weekly MACD is printing a bearish cross with a deepening histogram, price sits below both the 20- and 50-day SMAs, and the next high-conviction entry does not arrive until a test of the $95-97 zone, where the weekly EMA20 and 38.2% Fibonacci retracement converge. Conviction: Conviction for waiting is high because three independent signals — macro tightening punishing capital-intensive stories, a valuation that already discounts Q2's good news, and bearish momentum on the weekly chart — all point the same direction without requiring a single contested assumption.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All five voices agree the foundry pivot is the decisive variable: if Intel lands a second marquee 18A customer, the bull case accelerates; without one, the turnaround premium is an unsupported bet.
- All five see the current price as embedding flawless execution, with forward P/E multiples (52-63x) that double TSMC's and leave no cushion for the inevitable stumbles of a capital-intensive turnaround.
- All five acknowledge the Q2 2026 operational beat was real — revenue growth, foundry momentum, supply-constrained commentary — but not one voice treats a single quarter as sufficient to underwrite a structural call at $102.50.
- All five, including the two outright bears, identify the same support zone ($95-97) as the level where the balance-of-upside conversation meaningfully changes.
The real debate
- The Quality Rationalist and The Forensic Skeptic see structural business deterioration — negative ROE, negative ROIC, collapsing gross margins — as evidence the moat is permanently damaged, while The GARP Operator and The Intrinsic-Value Modeler see those same numbers as snapshots of a transition where Q2's revenue acceleration could mark the trough.
- The Macro Opportunist frames the objection as purely timing: the trend is intact but momentum is decaying, and the chart says the correction is unfinished, whereas The Forensic Skeptic and The Quality Rationalist frame the objection as business quality: even a $95 entry buys a company destroying capital at negative 7 basis points of ROIC.
The question it comes down to: Is Intel's foundry pivot a genuine turnaround with Q2 2026 as the inflection point, or is the market pricing a perfect outcome for a business still losing $11 billion annually with no second marquee customer secured?
The bottom line
- Trigger to flip bullish: A weekly close above $115 resistance on expanding volume, ideally paired with a marquee foundry customer announcement for the 18A node, would confirm the correction is over and the Stage 2 uptrend is resuming.
- Key support to watch: A pullback into $95-97 (weekly EMA20 and 38.2% Fibonacci retracement) with a bullish reversal candle and MACD histogram flattening would shift the balance of upside to downside to favorable, creating the entry that currently does not exist at $102.50.
- Risk to monitor: A break below $95 on expanding volume would signal the correction has further to run toward $80-85 and would confirm the turnaround premium is unwinding, flipping the call to outright bearish.
- Next catalyst: Q3 2026 earnings (guidance: $0.38 adjusted EPS) represent the next hard test — any miss at a 52-63x forward multiple would trigger severe compression, while a beat paired with foundry customer news would validate the Q2 inflection narrative.
- Further out: Any delay in the 14A or 18A process roadmap, or a debt downgrade as the balance sheet continues deteriorating, would undercut the entire foundry thesis regardless of price level.
contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · No direct position held in INTC · INTC verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s split verdict on INTC — and where they disagree.
The case for and against roughly balance — no clear edge at today's price.
NASDAQ · Information Technology · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BalancedMEDIUM confidence
Why
Intel has delivered a real turnaround — 25% revenue growth, positive free cash flow, and four consecutive earnings beats — but the stock's 12% pullback from $102.50 to $90 has not yet found a floor. Six distinct analytical frameworks converge on a BALANCED: the weekly correction still has room to run, insider selling contradicts the bullish narrative, and the foundry strategy remains unproven without a marquee customer. The $80-83 zone is the level where the debate shifts decisively toward BUY, while a weekly close below $73.62 would flip the call to SELL.Level to watch
Key resistance 94.72+5.2% from 90.07
Next catalyst
Trigger to confirm the dip: A weekly close above $95.37 (the EMA20) with the MACD histogram flattening or turning up would end the correction and signal that institutional buyers have stepped in.The panel's take
Verdict: BALANCED · Conviction: MEDIUM · Last price: 90.07 · Changed from WAIT
Panel: 1 Bullish · 4 Neutral · 1 Bearish → BALANCED
What changed since 2026-08-15:
- Price: 102.5 → 90.07 (-12.13%)
- Panel: 0 of 5 → 1 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer, The Scuttlebutt Growth Investor; removed The Quality Rationalist
- Trigger: SELL on a weekly close below $73.62 (the weekly EMA50), confirming the medium-term uptrend is broken and Stage 3 (distribution) has begun. BUY on a pullback to $80-83 with a bullish reversal candle on the weekly chart and the weekly MACD histogram flattening or turning up.
- Verdict: WAIT → BALANCED
The prior WAIT article flagged an impending pullback below $95, and that pullback has arrived — price declined 12% from $102.50 to $90 on expanding volume, landing the stock in no-man's-land: too far above the $80-83 support zone to buy, too far along in the correction to sell. The panel shifts to BALANCED because the correction they forecast is now materializing, and selling into a decline that was explicitly anticipated would contradict the original thesis, but the technical and insider signals all argue the move is not finished.
The prior WAIT article's trigger fired — price broke below $95 on expanding volume and has already fallen to $90, past the $95-97 buy zone — so the pullback INTC was waiting for is underway. The panel shifts to BALANCED: four of six voices see a real turnaround (25% YoY revenue, four consecutive earnings beats, FCF positive TTM) and analyst targets averaging $115 (+28%), so selling into a correction that was explicitly forecast is premature. But the same voices, plus the lone bear, agree the weekly correction has more room to run (RSI 50, no reversal candle), making a fresh add here the wrong call — hence Neutral over Bullish. The bear (The Forensic Skeptic) objects on deep-valuation grounds, not on whether the turnaround is real. What flips it to a SELL: a weekly close below $73.62 (the EMA50), breaking the medium-term trend and putting Stage 3 on the table.
Key levels
Key levels · INTC
USD · as of 2026-08-22Analyst consensus target 114.88 USD · range 75–200
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at $94.72–$97.02: the confluence of the monthly 38.2% Fibonacci retracement from the $142.35 high, the weekly 38.2% Fib, and the weekly EMA20 ($95.37), which rejected price in July and triggered the current correction. Key support is the $80.01–$83.02 band where the monthly and weekly 50% Fibonacci retracements cluster, representing the first zone of structural demand beneath the thin volume air gap between $80 and $100. Further support at $73.62 is the weekly EMA50 — the last trend filter before Stage 3 — and $65.30 is the monthly 61.8% Fib that would act as a historical accumulation zone if the correction deepens. The analyst consensus target of $114.88 sits 27.6% above the AS-OF price, above the immediate resistance band, reflecting the wider market's expectation that the turnaround ultimately reclaims the $110+ range.
What legendary investors think
We ran Intel past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: Intel's PEG of 0.78 — paying less than one times the growth rate — on a 25% YoY revenue acceleration and four consecutive earnings beats averaging $0.19 per surprise puts this turnaround squarely in the bargain-growth bucket. Conviction: Conviction is held back because every executive signals caution with their own money: the CFO sold 247,000 shares and multiple EVPs have been reducing positions, with zero insider purchases in the last 90 days.
The Asymmetric BargainerContrarian/Deep Value⚫ NeutralMed
Signal: The Dhandho structure fails on the downside test: at 54x forward earnings and 8.3x sales, any foundry misstep could send the stock back toward $50-60, making the 280% rally from $23.68 the easy money already captured. Conviction: Confidence firms on the positive FCF inflection and Coatue/Tiger Global adding in Q2 2026, but weakens because too many variables — a new CEO, $20.6B in net debt, and an unproven foundry strategy — must all break right for the thesis to work.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed
Signal: My base-case DCF values Intel at $78.50, roughly 13% below the current $90.07, which prices in a bull-case margin of 22% that requires a marquee foundry customer Intel has not yet landed. Conviction: Conviction firms on the tangible progress: FCF turned positive for the first time in three years, revenue growth hit its fastest clip since 2011, and operating cash flow surged to nearly $15B.
The Macro OpportunistMacro/Timing⚫ NeutralMed
Signal: The monthly Stage 2 uptrend remains intact, but the weekly chart still shows a bearish MACD cross, price below the EMA20 at $95.37, and an RSI stalled at 50 — no reversal signal and no oversold catalyst. Conviction: Conviction stays contained because the correction has a clear destination: the $80-83 zone, where the monthly and weekly 50% Fibonacci levels converge, offering a far tighter setup than buying here at $90.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: The stock trades at 3.6x book value and 54x forward earnings for a capital-intensive manufacturer with negative ROE and $20.6B in net debt, a valuation that requires net income to approach $30B — nearly double Intel's all-time peak of $14B in 2012. Conviction: Conviction is reinforced by the insider selling pattern — the CFO and multiple EVPs reducing positions while publicly delivering bullish guidance — and by the weekly MACD confirming exhausted momentum rather than a dip-buying opportunity.
The Scuttlebutt Growth InvestorGrowth/Management⚫ NeutralLow
Signal: Intel scores only 8 of 15 on my qualitative checklist: margins are depressed at 7.8% operating, employee sentiment sits at just 47% positive, and the moat is narrowing as TSMC and AMD gain share. Conviction: Conviction firms on the genuine turnaround signals — 25% revenue growth, gross margins recovering from 2.5% to 42%, and 10 long-term server CPU contracts — but weakens on the dissonance between management's bullish words and their collective selling.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The turnaround is real: 25% YoY revenue growth, four consecutive earnings beats, FCF turning positive for the first time in three years, and gross margins recovering from 2.5% to 42%.
- The weekly correction has more room to run: price below the EMA20 at $95.37, bearish MACD cross, RSI stalled at 50, and no reversal candle in sight — adding at $90 is premature.
- Insider selling is a flashing warning: the CFO and multiple EVPs have been selling shares through 2026 with zero insider purchases in the last 90 days, contradicting the bullish public narrative.
- The foundry strategy remains unproven: Fortinet is the only named customer and uses older process technology; without a marquee AI partner, the bull case on margins cannot be validated.
- Valuation has rerated aggressively from $23.68 to $90, compressing the margin of safety — 54x forward earnings and 3.6x book embed success that has not yet been delivered.
The real debate
- The GARP Operator and The Asymmetric Bargainer both see a turnaround story worth participating in at the right price, while The Forensic Skeptic argues the stock is overvalued by 2-3x against any conservative intrinsic-value framework and the turnaround is priced for a level of earnings Intel has never achieved.
- The Macro Opportunist and The Intrinsic-Value Modeler agree the correction is not done but disagree on what changes the setup: the Macro Opportunist wants a technical signal at $80-83, while The Intrinsic-Value Modeler wants a marquee foundry customer to raise his margin assumption from 18% toward 22%.
- The Scuttlebutt Growth Investor flags the qualitative weakness (8/15 checklist, 47% employee sentiment) that quantitative screens like the GARP Operator's PEG of 0.78 and the Macro Opportunist's Stage 2 trend analysis entirely miss.
The question it comes down to: Is the $80-83 zone a genuine accumulation opportunity in a recovering franchise, or the last stop before the weekly EMA50 at $73.62 breaks and the entire medium-term uptrend fails?
The bottom line
- Trigger to confirm the dip: A weekly close above $95.37 (the EMA20) with the MACD histogram flattening or turning up would end the correction and signal that institutional buyers have stepped in.
- Accumulation zone to watch: The $80-83 range, where the monthly and weekly 50% Fibonacci retracements converge, is the first level where the balance of upside to downside shifts meaningfully.
- Risk to monitor: A weekly close below $73.62 (the weekly EMA50) would breach the medium-term uptrend and put Stage 3 distribution on the table, flipping the call to SELL.
- Next catalyst: Q3 2026 earnings in late October: after four consecutive massive beats, a miss would be devastating given that 54x forward earnings already discounts perfection.
- Insider conviction signal: Any open-market purchase by the CEO or CFO would signal that the executives who know the business best believe the pullback has gone far enough to put their own capital at risk.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in INTC · INTC verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated